9.
Chung AW, Kumar MP, Arnold KB, et al. Dissecting polyclonal vaccine-induced humoral immunity against HIV using systems serology.
10.
Walsh EE, Frenck RW Jr, Falsey AR, et al. Safety and immunogenicity of two RNA-based Covid-19 vaccine candidates.
11.
Widge AT, Rouphael NG, Jackson LA, et al; mRNA-1273 Study Group. Durability of responses after SARS-CoV-2 mRNA-1273 vaccination.
12.
Anderson EJ, Rouphael NG, Widge AT, et al; mRNA-1273 Study Group. Safety and immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults.
13.
Jackson LA, Anderson EJ, Rouphael NG, et al; mRNA-1273 Study Group. An mRNA vaccine against SARS-CoV-2: preliminary report.
14.
Foleg
Origins of Disease newswise.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newswise.com Daily Mail and Mail on Sunday newspapers.
Is COVID Optimism Finally Overtaking Pessimism? Harvard Experts Weigh In plos.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from plos.org Daily Mail and Mail on Sunday newspapers.
By RACHEL LEESON | Ragon Institute Communications Image: NiseriN/iStock/Getty Images Plus
This article is part of Harvard Medical School’s of medicine, biomedical research, medical education, and policy related to the SARS-CoV-2 pandemic and the disease COVID-19.
Does an infection with SARS-CoV-2 render people protected from subsequent infections with the virus? And if so, how do we know which individuals have built up their immune defenses?
These have been two of the most important, and confounding, questions about COVID-19, and the answers hold valuable clues about the interplay between the human immune system and the virus responsible for the ongoing global pandemic.